Please assess the completion status of the following clinical trial:

Trial Title: Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Lists of Inclusion and Exclusion criteria:~Inclusion Criteria:~* adults or children weighting more than 5 kg~* axillary temperature \>=37.5°C at D0 or history of fever within the previous 24hrs~* confirmed Plasmodium falciparum monoinfection, with parasitemia\>1000mcl~* negative urinary pregnancy test for women of child bearing age before each new administration of treatment~Exclusion Criteria:~* presence of any serious or clinical danger sign of malaria: prostration, consciousness disorders, recent and repeated convulsions, respiratory distress, inability to drink, uncontrollable vomiting, macroscopic haemoglobinuria, jaundice, haemorrhagic shock, systolic BP\< 70 mmHg in adults or \< 50 mmHg in children, spontaneous bleeding, inability to sit or stand~* severe concomitant disease~* allergy to one of the investigational drugs.~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).